Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells

被引:78
作者
Garcon, Loic
Rivat, Christine
James, Chloe
Lacout, Catherine
Camara-Clayette, Valerie
Ugo, Valerie
Lecluse, Yann
Bennaceur-Griscelli, Annelise
Vainchenker, William
机构
[1] Inst Gustave Roussy, INSERM, U790, F-94805 Villejuif, France
[2] Hop Bicetre, Hematol Lab, Le Kremlin Bicetre, France
[3] CHU Brest, Hop Morvan, Hematol Lab, Inst Gustave Roussy, Villejuif, France
关键词
D O I
10.1182/blood-2005-10-009514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biologic hallmark of polycythemia vera (PV) is the formation of endogenous erythroid colonies (EECs) with an erythropoietin-independent differentiation. Recently, it has been shown that an activating mutation of JAK2 (V617F) was at the origin of PV. In this work, we studied whether the STAT5/Bcl-xL pathway could be responsible for EEC formation. A constitutively active form of STAT5 was transduced into human erythroid progenitors and induced an erythropoietin-independent terminal differentiation and EEC formation. Furthermore, Bcl-xL overexpression in erythroid progenitors was also able to induce erythroid colonies despite the absence of erythropoietin. Conversely, siRNA-mediated STAT5 and Bcl-xL knock-down in human erythroid progenitors inhibited colony-forming unit-erythroid (CFU-E) formation in the presence of Epo. Altogether, these results demonstrate that a sustained level of the sole Bcl-xL is capable of giving rise to Epo-independent erythroid colony formation and suggest that, in PV patients, JAK2(V617F) may induce EEC via the STAT5/Bcl-xL pathway.
引用
收藏
页码:1551 / 1554
页数:4
相关论文
共 22 条
[1]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[2]   Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts [J].
Dolznig, H ;
Habermann, B ;
Stangl, K ;
Deiner, EM ;
Moriggl, R ;
Beug, H ;
Müllner, EW .
CURRENT BIOLOGY, 2002, 12 (13) :1076-1085
[3]   Gfi-1B plays a critical role in tenninal differentiation of normal and transformed erythroid progenitor cells [J].
Garçon, L ;
Lacout, C ;
Svinartchouk, F ;
Le Couédic, JP ;
Villeval, JL ;
Vainchenker, W ;
Duménil, D .
BLOOD, 2005, 105 (04) :1448-1455
[4]   AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation [J].
Ghaffari, S ;
Kitidis, C ;
Zhao, W ;
Marinkovic, D ;
Fleming, MD ;
Luo, B ;
Marszalek, J ;
Lodish, HF .
BLOOD, 2006, 107 (05) :1888-1891
[5]   Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines [J].
Goncalves, F ;
Lacout, C ;
Féger, F ;
Cohen-Solal, K ;
Guichard, J ;
Cramer, E ;
Vainchenker, W ;
Duménil, D .
LEUKEMIA, 1998, 12 (09) :1355-1366
[6]   BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation [J].
Haughn, L ;
Hawley, RG ;
Morrison, DK ;
von Boehmer, H ;
Hockenbery, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) :25158-25165
[7]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[8]   A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].
Kralovics, R ;
Passamonti, F ;
Buser, AS ;
Teo, S ;
Tiedt, R ;
Passweg, JR ;
Tichelli, A ;
Cazzola, M ;
Skoda, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790
[9]   Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors [J].
Lacronique, V ;
Varlet, P ;
Mayeux, P ;
Porteu, A ;
Gisselbrecht, S ;
Kahn, A ;
Lacombe, C .
BLOOD, 1997, 90 (08) :3050-3056
[10]   Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis [J].
Neubauer, H ;
Cumano, A ;
Muller, M ;
Wu, H ;
Huffstadt, U ;
Pfeffer, K .
CELL, 1998, 93 (03) :397-409